Skip to main content
. 2022 Mar 14;5(3):e222037. doi: 10.1001/jamanetworkopen.2022.2037

Table. Baseline Characteristics of the Study Participants According to Living Arrangement Status (Living Alone vs Living With Others) and Treatment Assignment (Intensive vs Standard Blood Pressure Control) Among Black and Non-Black Individualsa.

Variables Treatment assignment of Black participants, No (%) Treatment assignment of non-Black participants, No (%)a
Living alone (N = 1001) Living with others (N = 1792) Living alone (N = 1713) Living with others (N = 4836)
Intensive (N = 493) Standard (N = 508) Intensive (N = 881) Standard (N = 911) Intensive (N = 860) Standard (N = 853) Intensive (N = 2435) Standard (N = 2401)
Sex
Female 255 (51.7) 257 (50.6) 372 (42.2) 382 (41.9) 414 (48.1) 389 (45.6) 636 (26.1) 615 (25.6)
Male 238 (48.3) 251 (49.4) 509 (57.8) 529 (58.1) 446 (51.9) 464 (54.4) 1799 (73.9) 1786 (74.4)
Age, mean (SD), y 65.3 (9.1) 65.4 (9.4) 63.5 (8.8) 63.7 (8.7) 71.7 (9.2) 71.9 (9.3) 68.7 (8.9) 68.5 (9.1)
Education status
Less than college 384 (77.9) 386 (76.0) 683 (77.5) 678 (74.4) 469 (54.5) 470 (55.1) 1295 (53.2) 1244 (51.8)
College or above 109 (22.1) 109 (24.0) 198 (22.5) 233 (25.6) 391 (45.5) 383 (44.9) 1140 (46.8) 1157 (48.2)
Insurance
Private 83 (16.9) 97 (19.2) 245 (27.8) 226 (24.8) 128 (14.9) 114 (13.4) 583 (24.0) 603 (25.1)
Public 319 (65.0) 323 (64.0) 463 (52.6) 514 (56.5) 673 (78.3) 678 (79.7) 1685 (69.2) 1624 (67.7)
Uninsured 89 (18.1) 85 (16.8) 172 (19.6) 170 (18.7) 59 (6.9) 59 (6.9) 166 (6.8) 173 (7.2)
Smoking status
Never 205 (42.1) 216 (43.1) 396 (45.5) 402 (44.5) 379 (44.6) 394 (46.9) 1073 (44.5) 1056 (44.2)
Current 118 (24.2) 119 (23.8) 206 (23.7) 196 (21.7) 91 (10.7) 77 (9.2) 224 (9.3) 209 (8.8)
Former 164 (33.7) 166 (33.1) 268 (30.8) 305 (33.8) 379 (44.6) 370 (44.0) 1117 (46.3) 1123 (47.0)
Alcohol intake 271 (55.2) 297 (58.8) 475 (54.3) 500 (55.2) 592 (69.0) 573 (69.5) 1641 (67.6) 1645 (68.6)
Baseline blood pressure, mean (SD), mm Hg
Systolic 140.0 (16.7) 139.4 (16.5) 139.2 (16.8) 140.4 (15.4) 139.9 (15.4) 141.5 (16.2) 139.7 (15.3) 138.8 (14.8)
Diastolic 80.6 (12.8) 80.4 (12.4) 81.5 (12.4) 81.8 (12.2) 75.6 (11.3) 76.2 (12.0) 77.5 (11.4) 76.8 (11.4)
Clinical cardiovascular disease 50 (10.1) 57 (11.2) 85 (9.7) 87 (9.6) 139 (16.2) 143 (16.8) 465 (19.1) 433 (18.0)
Subclinical cardiovascular disease 46 (9.3) 37 (7.3) 75 (8.5) 82 (9.0) 60 (7.0) 66 (7.7) 199 (8.2) 208 (8.7)
Statin use 162 (33.2) 181 (35.9) 268 (30.5) 332 (36.6) 377 (44.0) 380 (44.9) 1171 (48.4) 1182 (49.6)
Aspirin use 203 (41.2) 215 (42.4) 359 (40.9) 372 (40.9) 499 (58.1) 413 (48.5) 1345 (55.3) 1348 (56.3)
No. of antihypertensive medications
0 39 (7.9) 30 (5.9) 69 (7.8) 68 (7.5) 77 (9.0) 116 (13.6) 238 (9.8) 229 (9.5)
1 131 (26.6) 157 (30.9) 236 (26.8) 258 (28.3) 289 (33.6) 259 (30.4) 810 (33.3) 799 (33.3)
2 163 (33.1) 188 (37.0) 323 (36.7) 301 (33.0) 291 (33.8) 292 (34.2) 832 (34.2) 800 (33.3)
≥3 160 (32.4) 133 (26.2) 253 (28.7) 284 (31.2) 203 (23.6) 186 (21.8) 555 (22.8) 573 (23.9)
10-y Framingham cardiovascular disease risk %, median (IQR) 14.8 (11.3) 14.7 (12.6) 14.9 (11.3) 15.2 (12.3) 18.0 (15.9) 19.1 (15.1) 19.3 (13.4) 19.1 (13.9)
a

Non-Black individuals indicate those who identified as Alaskan Native, American Indian, Asian, Native Hawaiian, Pacific Islander, White, or other during the Systolic Blood Pressure Intervention Trial.